RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY

被引：0

作者：

Landewe, Robert B. M. ^{[1
]}

Poddubnyy, Denis ^{[2
]}

Rahman, Proton ^{[3
]}

Bolce, Rebecca ^{[4
]}

Liu-Leage, Soyi ^{[4
]}

Lisse, Jeffrey ^{[4
]}

Leung, Ann ^{[5
]}

Park, So Young ^{[4
]}

Gensler, Lianne S. ^{[6
]}

Bird, Paul ^{[7
]}

机构：

[1] Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands

[2] Charite, Hindenburgdamm, Germany

[3] Mem Univ Newfoundland, St John, NF, Canada

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

[5] Syneos Hlth, Morrisville, NY USA

[6] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[7] Conjoint Prof UNSW, Sydney, NSW, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2023年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

ARA-P70

引用

页码：37 / 38

页数：2

共 50 条

[31] Ixekizumab Significantly Improves Signs, Symptoms, and Spinal Inflammation of Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 16-Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial
van der Heijde, Desiree
Wei, James Cheng-Chung
Dougados, Maxime
Mease, Philip J.
Deodhar, Atul A.
Maksymowych, Walter P.
van den Bosch, Filip
Sieper, Joachim
Tomita, Tetsuya
Landewe, Robert B. M.
Mallbris, Lotus
Zhao, Fangyi
Adams, David
Pangallo, Beth
Carlier, Hilde
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[32] Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis: 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study
Landewe, Robert B. M.
Rudwaleit, Martin
van der Heijde, Desiree
Dougados, Maxime
Maksymowych, Walter P.
Braun, Jurgen
Deodhar, Atul A.
Stach, Christian
Hoepken, Bengt
Coteur, Geoffroy
Kielar, Danuta
Fichtner, Andreas
Arledge, Terri
Sieper, Joachim
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S336 - S337
[33] Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study
Deodhar, Atul
Blanco, Ricardo
Dokoupilova, Eva
Hall, Stephen
Kameda, Hideto
Kivitz, Alan J.
Poddubnyy, Denis
van de Sande, Marleen
Wiksten, Anna S.
Porter, Brian O.
Richards, Hanno B.
Haemmerle, Sibylle
Braun, Juergen
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (01) : 110 - 120
[34] Efficacy and Safety of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis: 16-Week Results from a Phase 3 Study
Xue, Yu
Hu, Jiankang
Liu, Dongzhou
Li, Jingyang
Wu, Huaxiang
Tan, Chunyu
Dai, Lie
Liu, Mengru
Li, Hongying
Zou, Hejian
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 796 - 798
[35] Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study
Findling, Robert L.
Chang, Kiki
Robb, Adelaide
Foster, Vicki J.
Horrigan, Joseph
Krishen, Alok
Wannil, Art
Kraus, John E.
DelBello, Melissa
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (12): : 1020 - 1031
[36] PHENOBARBITAL FOR ACUTE ALCOHOL WITHDRAWAL: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
Rosenson, Jonathan
Clements, Carter
Simon, Barry
Vieaux, Jules
Graffman, Sarah
Vahidnia, Farnaz
Cisse, Bitou
Lam, Joseph
Alter, Harrison
JOURNAL OF EMERGENCY MEDICINE, 2013, 44 (03): : 592 - +
[37] Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study
Gerra, G
Zaimovic, A
Giusti, F
Moi, G
Brewer, C
ADDICTION BIOLOGY, 2002, 7 (04) : 385 - 395
[38] Efficacy and Safety Outcomes in Patients with Non-Radiographic Axial Spondyloarthritis Treated with Certolizumab Pegol: Results from the First 52-Week Randomized Placebo-Controlled Study (NCT02552212)
Deodhar, Atul A.
Gensler, Lianne S.
Kay, Jonathan
Maksymowych, Walter P.
Haroon, Nigil
Landewe, Robert B. M.
Rudwaleit, Martin
Hall, Stephen
Bauer, Lars
Hoepken, Bengt
de Peyrecave, Natasha
Kilgallen, Brian
van der Heijde, Desiree
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[39] Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
Deodhar, Atul
Poddubnyy, Denis
Pacheco-Tena, Cesar
Salvarani, Carlo
Lespessailles, Eric
Rahman, Proton
Jarvinen, Pentti
Sanchez-Burson, Juan
Gaffney, Karl
Lee, Eun Bong
Krishnan, Eswar
Santisteban, Silvia
Li, Xiaoqi
Zhao, Fangyi
Carlier, Hilde
Reveille, John D.
Antolini, Christopher
Azevedo, Valderilio
Barkham, Magnus
Rodriguez, Aaron Alejandro Barrera
Berman, Alberto
Blicharski, Tomasz
Brzezicki, Jan
Burmester, Gerd
Carrio, Judith
Collantes, Eduardo
Combe, Bernard
Cons-Molina, Fidencio
Cortes-Maisonet, Gregorio
Dudek, Anna
Barragan, Sergio Duran
Elkayam, Ori
Flint, Kathleen
Galeazzi, Mauro
Gaylis, Norman
Goddard, David
Fernandez, Carlos Gonzalez
Goupille, Philippe
Masmitja, Jordi Gratacos
Greenwald, Maria
Gremese, Elisa
Hong, Seung Jae
Howell, Mary
Hrycaj, Pawel
Ince, Akgun
Ju, Ji Hyeon
Kaine, Jeffrey
Kang, Seong Wook
Keiserman, Mauro
Kim, Tae-Hwan
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (04) : 599 - 611
[40] Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
Schwartz, Sherwyn
Etropolski, Mila
Shapiro, Douglas Y.
Okamoto, Akiko
Lange, Robert
Haeussler, Juergen
Rauschkolb, Christine
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 151 - 162

← 1 2 3 4 5 →